Prioritizing the Patient Perspective in Psoriasis Care and Communications
The patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is making
Wednesday, January 18, 2023
International Psoriasis Council
Menu
Advancing Knowledge. Enhancing Care.
Menu
COVID-19 & Psoriasis Resource Center
To assist dermatologists and the patients they serve, the IPC is collecting information from around the world on coronavirus and psoriasis. If you have a resource on COVID-19 and psoriasis to add, please submit it to IPC.
Latest News on COVID-19 & Psoriasis
Revised IPC Statement on COVID-19
This revised statement is based on expert opinion and should be interpreted in the context of local policies and emerging
Monday, December 19, 2022
PsoProtect Registry Data Update
PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data
Wednesday, June 15, 2022
IPC Resources
IPC Statement on COVID-19 & Psoriasis
Read the statement from IPC’s Board of Directors based on the current understanding of the impact of COVID-19 and psoriasis.
Commentaries
Psoriasis experts worldwide give their take on the most important COVID-19 publications.
Treatment Guidelines
Information from around the world on psoriasis and the coronavirus to assist dermatologists and the patients they serve.
Videos
Videos on current research and treatment strategies regarding psoriasis and COVID-19 from IPC congress symposia and webinars presented by IPC experts.
Research
PsoProtect International Registry
PsoProtect is an international registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. The registry seeks to improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis. This information will inform clinicians when assessing risk and treating COVID-19 in patients with psoriasis.